Background: extracellular matrix (ECM) components are instrumental in maintaining homeostasis and muscle fiber functional integrity. Skeletal muscle hypertrophy is associated with ECM remodeling. Specifically, recent studies have reported the involvement of matrix metalloproteinases (MMPs) in muscle ECM remodeling. However, the functional role of MMPs in muscle hypertrophy remains largely unknown. Methods: in this study, we examined the role of MMP-2 in skeletal muscle hypertrophy using a previously validated method where the plantaris muscle of mice were subjected to mechanical overload due to the surgical removal of synergist muscles (gastrocnemius and soleus). Results: following two weeks of overload, we observed a significant increase in MMP-2 activity and up-regulation of ECM components and remodeling enzymes in the plantaris muscles of wild-type mice. However, MMP-2 knockout mice developed significantly less hypertrophy and ECM remodel-ing in response to overload compared to their wild-type littermates. Investigation of protein synthesis rate and Akt/mTOR signaling revealed no difference between wild-type and MMP-2 knockout mice, suggesting that a difference in hypertrophy was independent of protein synthesis. Conclusion: taken together, our results suggest that MMP-2 is a key mediator of ECM remodeling in the setting of skeletal muscle hypertrophy.
Introduction
Skeletal muscles possess great plasticity, which allows them to increase or decrease their size throughout adulthood, responding to both physical and chemical signals. In adult mammalian muscle, increases in muscle mass occur primarily as a result of increase in muscle fiber size (hypertrophy) instead of muscle fiber numbers (hyperplasia). The most vigorous muscle hypertrophy happens during puberty in response to an increase of anabolic hormonal signaling 1, 2 . Increased mechanical loading, as in resistance strength training, can also induce muscle hypertrophy in adult mammals. Skeletal muscle is a well-organized tissue that is composed of myofibers and an extracellular matrix (ECM) that connects these fibers. The ECM forms a complex architecture that not only supports blood vessels and nerves, and connects myofibers, but also integrates them to ensure optimal force transmission within the muscle [3] [4] [5] [6] . There has been a growing body of evidence showing that ECM participates in fiber force transduction, maintains normal muscle function, stimulates muscle progenitor cell differentiation, and affects a muscle's ability to adapt to disease and injury 7, 8 . Previous studies have suggested that hypertrophic changes observed in muscle tissue are accompanied by the activation and contribution of satellite cells, which are released from the muscle fiber basement membrane and typically fuse into the preexisting muscle fibers to contribute to skeletal muscle hypertrophy 9, 10 . However, how much these cells contribute to hypertrophy remains largely unknown. The ECM is under vigorous remodeling during many physiological and pathological processes, including muscle growth and regeneration. Many previous studies including our own have shown that the matrix force transducer (Grass Tech, Astro-Med Inc) using suture silk. The femur was securely clamped and fixed. A bipolar electrode was placed in the sciatic nerve to stimulate muscle contraction. Muscle maximum isometric tetanic force was measured through the PolyView16 chart recorder (Grass Tech, Astro-Med Inc) 20 .
Muscle harvesting
Animals were euthanized after mechanical testing. Plantaris muscles were harvested, weighed, and processed accordingly for histological or biochemical analysis (Tab. 1).
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
To isolate total RNA, muscle samples were homogenized in 500 μL of Trizol® reagent (Invitrogen Inc., Carlsbad, CA) according to the manufacturer's instructions 21 . Isolated RNA was quantified and normalized to synthesize cDNA using a Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Bioscience Inc., Indianapolis, IN.). qRT-PCR was performed to quantify the expression of ECM components and remodeling markers using a Light Cycler 480 SYBR Green I Master kit (Roche Applied Bioscience Inc.). Primer sequences are listed in Table 2 . Amplification reactions were performed with 40 cycles of (95° C for 15 sec; 56° C for 45 s; and 72° C for 1 min), and normalized to GAPDH. Fold change in mR-NA expression was calculated by using ∆∆CT 21 .
Western blot analysis
To isolate total protein, muscle samples were homogenized in 500 μL of T-PER solution with a protease inhibitor cocktail (Sigma-Aldrich Inc., St. Louis, MO) as described previously 21 . The homogenates were centrifuged at 2,500 X g at 4° C for 10 min. After determining the protein concentration, 20 μg of protein was loaded on 10% NUPAGE Bis-Tris gels and transferred to PVDF membranes (Invitrogen Inc.) that were blocked MMP-2 induced skeletal muscle hypertrophy 447 Muscles, Ligaments and Tendons Journal 2014; 4 (4): 445-454 metalloproteinase (MMP) enzyme super family plays a principle role in skeletal muscle atrophy and ECM remodeling [11] [12] [13] [14] . A subgroup of the MMP family, gelatinases (consisting of MMP-2 and MMP-9), digests type IV collagen, the major component of basement membrane in the ECM. In a recent study, Clave et al. showed the up-regulation of MMP-2 following a hypertrophic stimulus 15 . However, to our knowledge, the functional role of MMP-2 following overload induced muscle hypertrophy remains undefined. Therefore, in this study, we examine the functional role of MMP-2 in skeletal muscle hypertrophy using a functional overload, synergist ablation, model of the plantaris muscle in MMP-2 knockout and wild-type mice. We hypothesized that deletion of the MMP-2 gene will significantly impair ECM remodeling and reduce the extent of muscle hypertrophy observed.
Materials and methods
Our study meets the ethical standards of the journal 16 .
Synergist ablation surgery
Hypertrophy of the plantaris muscle was induced in mature (10 month old) male MMP-2 knockout (KO) mice and their wild-type (WT) littermates by functional overload, which was induced by bilateral achillotenotomy and removal of synergist muscles (gastrocnemius and soleus) according to a previously validated method [17] [18] [19] . Table 1 shows the number of animals used for the various characterization experiments. All procedures were approved by the San Francisco Veterans Affairs Medical Center (SFVAMC) Institutional Animal Care and Use Committee (IACUC).
Muscle biomechanical testing
All animals underwent in situ muscle mechanical testing two weeks postoperatively as previously described 11 . Animals were anesthetized with flurane and the plantaris tendon was isolated and attached to a and incubated in primary and secondary antibodies as previously described 21 . The following rabbit-anti-rat primary antibodies were used at a dilution of 1:500: anti-mTOR (cat# 2972), anti-phospho-mTOR (cat# 2971), anti-Akt (cat# 9272), anti-phospho-Akt (cat# 9271), anti-S6K1 (cat# 9202), anti-phospho-S6K1 (cat# 9208), and anti-β actin (cat# 4967). A HRP conjugated goatanti-rabbit secondary antibody (cat# 7074) (Cell Signaling Technology Inc., Danvers, MA) was used at a dilution of 1:10,000. Blots were developed using enhanced chemiluminescence (ECL) plus reagent (GE Healthcare Inc., Piscataway, NJ), imaged, and quantified using Image J Software (NIH).
Zymography
Zymography was performed to verify activity MMP-2 using the plantaris muscle protein extract from both surgical and control groups of WT mice. Twenty microgram of protein was loaded on 10% gelatin SDS-PAGE gels as described previously 11, 13 . The intensity of MMP-2 pro-enzyme and active bands was quantified using Image J software (NIH).
In vivo SUnSET
To measure the change of in vivo protein synthesis, we used a recently developed nonradioactive technique called surface sensing of translation (SUn-SET) 22 . This technique utilizes puromycin, an aminonucleoside antibiotic, that resembles a portion of an aminoacylated tRNA. Puromycin enters the A site of the ribosome from where it is transferred to the growing chain. It causes premature termination and therefore provides an indirect method of measuring global protein synthesis that can be evaluated via standard laboratory techniques such as western blotting. MMP-2 KO mice and their WT littermates from both the surgical and control groups were anesthetized and given an intraperitoneal injection of 0.04 μmol/g puromycin dissolved in 1 mL of PBS 22, 23 . Mice were under general anesthesia with 2% isoflurane in oxygen before and after injection. Animals were sacrificed exactly 30 minutes after injection and plantaris muscles were harvested and homogenized for western blotting as described above. PVDF membrane was probed with an anti-puromycin (3RH11, cat# EQ0001) antibody (KeraFAST Inc., Boston, MA) at a dilution of 1:1000. After overnight incubation with the primary antibody, the blot was probed with a fluorescent IRDye 800CW Goat anti-Rabbit IgG secondary (cat#926-32211) antibody (LI-COR Biosciences, Lincoln, NE) and imaged using the Odyssey Infrared Imaging System (LI-COR Biosciences) and quantified as described above. Gel loading was verified via coomassie blue staining.
Total collagen staining
Muscle samples for histological analysis were frozen in isopentane precooled in liquid nitrogen and were sectioned at -20° C at a thickness of 10μm. Masson's Trichrome Staining for total ECM collagen was performed for histological analysis. Fiber cross-sectional area and number were measured using Image J software.
Statistical Analysis
Two-way ANOVA with Tukey's HSD post-hoc comparison was used for data analysis to compare differences among groups (WT hypertrophy, KO hypertrophy, WT control, and KO control). A non-parametric Mann-Whitney U test was used to analyze the distribution of muscle fibers. Significance was defined as a p<0.05. Data are presented as mean ± standard error.
Results

Increase in MMP-2 activity following overload
Zymography showed that the active form of MMP-2 was significantly up-regulated in plantaris muscles af- Table 2 . Primers used for qRT-PCR. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH); myogenic differentiation 1 (MyoD); myogenin; collagen, type 1, alpha 1 (Col I); collagen type IV (Col IV); fibronectin; g-laminin; matrix metalloproteinase 2 (MMP-2); matrix metalloproteinase 9 (MMP-9); matrix metalloproteinase 13 (MMP-13).
Gene
Forward (5'Ǟ3') Reverse (5'Ǟ3')
CGTGTACGGACCCGAAGCGG AGGCAGAGTAGGAGCGGCCC MMP- 13 ACTCCCTGTTGGTCCCTGCCC GGGTGCAGGCGCCAGAAGAAT ter two weeks of hypertrophy compared to control WT mice (p<0.001) (Fig. 1) . The pro-enzymatic form of MMP-2 was not significantly up-regulated (p=0.0645) ( Fig. 1) .
Increase in gene expression of ECM components and MMPs following overload
Following two weeks of overload, qRT-PCR showed that myogenic markers-myogenic differentiation 1 (MyoD) and myogenin were significantly increased in both MMP-2 WT and KO mice compared to their controls. Expression of key ECM components, including collagen type (Col I), collagen type IV (Col IV), fibronectin, and laminin, was also significantly increased following overload in both MMP-2 WT and KO mice compared to their controls. While MMP-9 and MMP-13 were up-regulated in both WT and KO mice following overload, MMP-2 up-regulation was seen only in WT mice. Interestingly, the up-regulation of all these genes (including MMPs) was significantly 
Reduced increase in muscle weight and mechanical force in MMP-2 KO mice following overload
Robust hypertrophy was seen in plantaris muscles of WT mice following two weeks of overload compared to non-surgery WT controls as evident by the significant increase observed in wet weight (p<0.001). However, no significant difference in muscle weight was observed between MMP-2 KO control mice and KO mice that underwent overload. In response to overload, plantaris wet weight was significantly greater in WT mice compared to KO mice (p=0.014). While isometric tetanic force increased significantly in response to overload in WT and KO mice compared to their respective controls (p<0.001 for WT mice, p=0.0015 for MMP-2 KO mice), tetanic force was significantly greater in WT mice compared to KO mice following overload (p=0.0012) ( Fig. 2) . 
Reduced increase in muscle fiber number and cross-sectional area in MMP-2 KO mice following overload
Masson's Trichrome Staining showed plantaris muscle of MMP-2 KO mice were significantly smaller than those of WT mice following overload. However, no visual differences in total collagen content were observed ( Fig. 3) . Muscle fiber number significantly increased in WT (p<0.001) and MMP-2 KO mice (p=0.0023) in response to overload compared to their respective controls. However, MMP-2 KO mice had less muscle fibers compared to their WT littermate mice following overload (p=0.029) ( Fig. 4) . A significant increase in mean fiber cross-sectional area was seen following overload in both WT and KO mice (P<0.001). The average fiber cross-sectional area in response to overload increased 18.5% in WT mice compared to their controls (increased from 1426 μm 2 to 1750 μm 2 ). However, the average fiber cross-sectional area increased only 12.5% in MMP-2 KO mice compared to their controls (increased from 1758 μm 2 to 2011 μm 2 ) ( Fig. 4) .
Reduced hypertrophy in MMP-2 KO mice is not due to reduced protein synthesis
Though the rate of total protein synthesis was significantly increased in both WT and KO mice following overload compared to control mice (p=0.0046 for WT mice, p=0.012 for KO mice), there was no significant differences between either MMP-2 KO and WT control groups or between MMP-2 KO and WT groups following overload (Fig. 5 ). We further investigated the activity of the Akt/mTOR signaling pathway, a key pathway that regulates protein synthesis, in plantaris muscles from MMP-2 KO and WT mice. Western-blot analysis of Akt, phospho-Akt, mTOR, phospho-mTOR, S6K1, phospho-S6K1 showed no significant difference between WT and MMP-2 KO mice following overload (Fig. 6 ). This suggests that MMP-2 KO mice have similar protein synthesis rate before and after overload to WT mice. Reduced plantaris muscle hypertrophy in MMP-2 KO mice was not due to changes in protein synthesis.
Discussion
Despite the importance of ECM remodeling in maintaining myofiber function and structural integrity, ECM remodeling during muscle hypertrophy remains under investigated. In this study, we saw active muscle ECM remodeling following overload-induced muscle hypertrophy as evident by the up-regulation of ECM components andremodeling enzymes. Deletion of the MMP-2 gene significantly decreased the extent of hypertrophy observed in the mice and, thereby suggests that MMP-2 is a pertinent contributor to muscle hypertrophy in our model. Reduced muscle hypertrophy in MMP-2 KO was most likely due to reduced muscle Semiquantitative measurement of band intensity (C) showed higher global protein activity following 2 weeks of plantaris hypertrophy. However, no significant difference was found between MMP-2 KO and WT mice in either control or hypertrophy group (* indicates significant difference).
ECM remodeling rather than reduced muscle protein synthesis. Taken together, our finding suggests that MMP-2 plays a critical role in skeletal muscle hypertrophy by regulating muscle ECM remodeling. Muscle ECM remodeling consists of both degradation of existing ECM components and synthesis of new components. Our qRT-PCR results demonstrate significant increase in gene expression of both ECM degradative enzymes including MMP-2, -9, -13, as well as key ECM components including type IV collagen, fibronectin, and g-laminin. This data suggests that robust ECM degradation and new ECM synthesis occur simultaneously during muscle hypertrophy. Although the expression of these ECM markers was upregulated in MMP-2 KO mice following overload, the fold change of these genes was significantly lower than their WT littermates. Deletion of the MMP-2 gene significantly hampers the up-regulation of key ECM components and remodeling enzymes. This data suggests that MMP-2 may serve as a central regulator of ECM remodeling in the setting of muscle hypertrophy. MMP-2 is an enzyme that is involved in basement membrane remodeling. Type IV collagen is a known substrate of MMP-2, which undergoes elevated expression in various physiological and pathological events related to basement membrane metabolism, such as tissue repair, angiogenesis, and arterial enlargement 12, [24] [25] [26] [27] . In our preliminary data (not presented), we observed significantly increased MMP-2 activity and degradation of type IV collagen in WT mice following overload. However, type IV collagen was well preserved in MMP-2 KO mice following overload. This dichotomy in degradation of type IV collagen suggests that MMP-2 plays a dominant role in basement membrane degradation following skeletal muscle hypertrophy. However, to confirm our staining an antibody that specifically binds to fragmented type IV collagen is needed. MyoD and myogenin are key transcription factors responsible for muscle progenitor cell myogenesis. Previous studies have shown that these transcription factors play key roles in muscle hypertrophy 28, 29 . In line with these studies, we observed significantly increased expression of these two genes in plantaris muscles following overload, thereby further indicating the role of these two transcription factors in muscle hypertrophy. The expression level of these two genes was significantly lower in hypertrophic muscles of MMP-2 KO mice compared to WT mice. This is consistent with the reduced muscle hypertrophy observed in MMP-2 KO mice.
In order to verify that decreased ECM remodeling as opposed to decreased protein synthesis resulted in decreased hypertrophy in MMP-2 KO mice, we assessed total protein synthesis rate and a key protein synthesis pathway, the Akt/mTOR signaling pathway 30 . Our evaluation of protein synthesis shows that the difference in hypertrophy we observed between WT and KO MMP-2 mice is unrelated to differences in protein synthesis rate. Likewise, no difference in phosphorylation was seen for Akt, mTOR, and S6K1 between wild-type and KO hypertrophied mice. These results further support that reduced hypertrophy seen in MMP-2 KO mice was due to reduced ECM remodeling rather than changes in protein synthesis and/or phosphorylation. Although our study revealed the critical role of MMP-2 in skeletal muscle hypertrophy, there are several limitations to this study. We only assessed hypertrophy with a single time-point of two weeks. However, many studies have shown that two weeks is an appropriate time point to assess plantaris muscle hypertrophy following synergist ablation surgery 13, 31 . In addition to these studies, in this study we saw a robust hypertrophic response following two weeks in plantaris muscles and therefore we believe that two weeks was an appropriate time point for assessment of hypertrophy. Future studies will evaluate hypertrophy following longer time-points. Secondly, no sham surgery was performed in the control group. Therefore, any inflammation induced by surgery was unaccounted. Since we are comparing the MMP-2 KO and WT mice in surgery and control groups separately, the effects of inflammation should not affect the overall conclusion. Third, only one hypertrophy model (functional overload) was used in this study. Other hypertrophy models, like exercise-induced hypertrophy will be considered for a future study. Finally, the expression and activity of internal MMP-2 activator and inhibitors (like MMP-14 and TIMPs) were not measured in this study. Future work is needed to establish the MMP-2 regulating network in skeletal muscle hypertrophy.
In summary, we report that deletion of the MMP-2 gene in mice significantly reduces muscle hypertrophy compared to their KO littermates following overload. Our finding suggests that MMP-2 plays a critical role in regulating muscle size and contractility in the setting of muscle hypertrophy via regulating muscle ECM remodeling.
